Privia Health Group Hits New 52-Week High at $27.96

Privia Health Group, Inc. has reached a significant milestone by hitting a new 52-week high of USD 27.96 on July 13, 2026. This achievement underscores the company's strong performance in the insurance sector, particularly as it has recorded a remarkable 64.54% increase over the past year, significantly outperforming the S&P 500, which has seen a gain of 20.06% during the same period. With a market capitalization of USD 2,476 million, Privia Health Group is classified as a small-cap company. The stock's price-to-earnings (P/E) ratio stands at 108.00, indicating a premium valuation relative to its earnings. Additionally, the company has a price-to-book ratio of 3.36, reflecting its market valuation compared to its book value. Despite not offering a dividend, Privia Health Group's return on equity is reported at 3.11%. The company’s financial metrics and recent performance highlight its position within the insurance industry, marking a notable achievement with this new high.